A Study of Belotero® Intense Lidocaine for Lip Augmentation
NCT05773066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2026-08-18
Summary
The purpose of this study is to demonstrate the safety and effectiveness of Belotero Intense Lidocaine (BIL) for lip augmentation in subjects with upper and/or lower lip deficit.
Conditions
- Lip Augmentation
Interventions
- DEVICE
-
Belotero® Intense Lidocaine
Dermal hyaluronic acid (HA) filler for lip augmentation.
- DEVICE
-
Restylane® Silk
HA gel for lip augmentation.
Sponsors & Collaborators
-
Merz North America, Inc.
lead INDUSTRY
Principal Investigators
-
Merz Medical Expert · Merz North America, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-03
- Primary Completion
- 2023-10-16
- Completion
- 2024-09-26
- FDA Device
- Yes
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT07162766 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05750069 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT03663010 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05597826 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT00579176 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT00747266 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05379335 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05701761 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT06156696 ·Status: WITHHELD
-
Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia
NCT05746286 ·Status: COMPLETED ·Phase: NA
-
The BD Liverty™ TIPS Stent Graft Study
NCT05711316 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05687786 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT01906736 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05270304 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT04703309 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT07339046 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT02576210 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05796999 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05741463 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT04116866 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT06985966 ·Status: WITHHELD
-
EASEE® System Pivotal Study for the United States of America
NCT07301346 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT04630106 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05200026 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT03182660 ·Status: WITHHELD